Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Precision Optics Corporation, Inc. (POCI)

    Price:

    4.21 USD

    ( - -0.11 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    POCI
    Name
    Precision Optics Corporation, Inc.
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    Price
    4.210
    Market Cap
    32.502M
    Enterprise value
    33.536M
    Currency
    USD
    Ceo
    Joseph N. Forkey
    Full Time Employees
    83
    Website
    Ipo Date
    1992-01-16
    City
    Gardner
    Address
    22 East Broadway

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Hologic, Inc.

    VALUE SCORE:

    6

    Symbol
    HOLX
    Market Cap
    16.819B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    2nd position

    DENTSPLY SIRONA Inc.

    VALUE SCORE:

    9

    Symbol
    XRAY
    Market Cap
    2.554B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    The best

    Pro-Dex, Inc.

    VALUE SCORE:

    10

    Symbol
    PDEX
    Market Cap
    138.961M
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -4.728
    P/S
    1.341
    P/B
    3.506
    Debt/Equity
    0.366
    EV/FCF
    -11.049
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    1.444
    Earnings yield
    -0.211
    Debt/assets
    0.149
    FUNDAMENTALS
    Net debt/ebidta
    -0.391
    Interest coverage
    -36.728
    Research And Developement To Revenue
    0.041
    Intangile to total assets
    0.385
    Capex to operating cash flow
    -0.218
    Capex to revenue
    0.023
    Capex to depreciation
    2.249
    Return on tangible assets
    -0.492
    Debt to market cap
    0.104
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    0.512
    P/CF
    -12.721
    P/FCF
    -10.449
    RoA %
    -30.212
    RoIC %
    -48.975
    Gross Profit Margin %
    9.699
    Quick Ratio
    0.619
    Current Ratio
    1.047
    Net Profit Margin %
    -28.330
    Net-Net
    -0.894
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.414
    Revenue per share
    3.165
    Net income per share
    -0.897
    Operating cash flow per share
    -0.340
    Free cash flow per share
    -0.414
    Cash per share
    0.114
    Book value per share
    1.209
    Tangible book value per share
    0.066
    Shareholders equity per share
    1.209
    Interest debt per share
    0.467
    TECHNICAL
    52 weeks high
    6.040
    52 weeks low
    3.770
    Current trading session High
    4.495
    Current trading session Low
    4.200
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.316
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.500
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.071
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - General
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.861
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.279
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.135
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.633
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.208
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.072
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    -3.5747915999999997%
    P/E
    -3.074
    DESCRIPTION

    Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

    NEWS
    https://images.financialmodelingprep.com/news/precision-optics-q2-earnings-call-highlights-20260219.png
    Precision Optics Q2 Earnings Call Highlights

    defenseworld.net

    2026-02-19 04:06:50

    Precision Optics (NASDAQ: POCI) reported record revenue in its fiscal second quarter ended Dec. 31, 2025, as strong demand in two large production programs continued to build, though the company said manufacturing inefficiencies and yield issues weighed heavily on margins and profitability. Record quarterly revenue driven by production programs CEO Dr. Joe Forkey said second-quarter revenue

    https://images.financialmodelingprep.com/news/precision-optics-corporation-inc-poci-q2-2026-earnings-call-20260217.jpg
    Precision Optics Corporation, Inc. (POCI) Q2 2026 Earnings Call Transcript

    seekingalpha.com

    2026-02-17 20:14:59

    Precision Optics Corporation, Inc. (POCI) Q2 2026 Earnings Call Transcript

    https://images.financialmodelingprep.com/news/precision-optics-schedules-second-quarter-of-fiscal-year-2026-20260213.jpg
    Precision Optics Schedules Second Quarter of Fiscal Year 2026 Conference Call for February 17, 2026

    globenewswire.com

    2026-02-13 09:00:00

    GARDNER, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's second quarter fiscal year 2026 financial results on Tuesday, February 17, 2026, at 5:00 p.m. ET.

    https://images.financialmodelingprep.com/news/financial-contrast-imris-otcmktsimrsq-versus-precision-optics-nasdaqpoci-20251208.png
    Financial Contrast: Imris (OTCMKTS:IMRSQ) versus Precision Optics (NASDAQ:POCI)

    defenseworld.net

    2025-12-08 01:28:52

    Precision Optics (NASDAQ: POCI - Get Free Report) and Imris (OTCMKTS:IMRSQ - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation. Institutional and Insider Ownership 13.7% of Precision Optics shares

    https://images.financialmodelingprep.com/news/orthopediatrics-nasdaqkids-vs-precision-optics-nasdaqpoci-financial-survey-20251121.png
    OrthoPediatrics (NASDAQ:KIDS) vs. Precision Optics (NASDAQ:POCI) Financial Survey

    defenseworld.net

    2025-11-21 02:33:10

    Precision Optics (NASDAQ: POCI - Get Free Report) and OrthoPediatrics (NASDAQ: KIDS - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, dividends and risk. Analyst Ratings This is a breakdown of recent

    https://images.financialmodelingprep.com/news/precision-optics-corporation-inc-poci-q1-2026-earnings-call-20251113.jpg
    Precision Optics Corporation, Inc. (POCI) Q1 2026 Earnings Call Transcript

    seekingalpha.com

    2025-11-13 22:41:37

    Precision Optics Corporation, Inc. ( POCI ) Q1 2026 Earnings Call November 13, 2025 5:00 PM EST Company Participants Joseph Forkey - CEO, President, Treasurer & Director Wayne Coll - CFO & Secretary Conference Call Participants Robert Blum - Lytham Partners, LLC Presentation Operator Good afternoon, and welcome to the Precision Optics Q1 '26 Earnings Event. [Operator Instructions] Please also note today's event is being recorded.

    https://images.financialmodelingprep.com/news/precision-optics-reports-first-quarter-fiscal-year-2026-financial-20251113.jpg
    Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results

    globenewswire.com

    2025-11-13 16:30:00

    GARDNER, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its first quarter fiscal year 2026 for the period ended September 30, 2025.

    https://images.financialmodelingprep.com/news/precision-optics-announces-product-development-agreement-to-develop-custom-20251111.jpg
    Precision Optics Announces Product Development Agreement to Develop Custom High-End Borescope for Jet Engines

    globenewswire.com

    2025-11-11 09:00:00

    GARDNER, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the receipt of a product development order to design and build a next generation borescope system to be used to inspect the inside of jet engines from a large aerospace and defense company.

    https://images.financialmodelingprep.com/news/precision-optics-announces-product-development-agreement-to-deliver-nextgeneration-20251107.jpg
    Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots

    globenewswire.com

    2025-11-07 09:00:00

    GARDNER, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the receipt of a product development order to build sub-assemblies that will support an advanced augmented reality (AR) system for US Air Force fighter pilot training, powered by POC's next-generation optical sub-assembly design and manufacturing technologies.

    https://images.financialmodelingprep.com/news/precision-optics-schedules-first-quarter-of-fiscal-year-2026-conference-20251106.jpg
    Precision Optics Schedules First Quarter of Fiscal Year 2026 Conference Call for November 13, 2025

    globenewswire.com

    2025-11-06 16:15:00

    GARDNER, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's first quarter fiscal year 2026 financial results on Thursday, November 13, 2025, at 5:00 p.m.

    https://images.financialmodelingprep.com/news/precision-optics-to-participate-in-the-lytham-partners-fall-20250930.jpeg
    Precision Optics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

    globenewswire.com

    2025-09-30 08:00:00

    GARDNER, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025.

    https://images.financialmodelingprep.com/news/precision-optics-corporation-inc-poci-q4-2025-earnings-call-20250929.jpg
    Precision Optics Corporation, Inc. (POCI) Q4 2025 Earnings Call Transcript

    seekingalpha.com

    2025-09-29 19:07:42

    Precision Optics Corporation, Inc. (NASDAQ:POCI ) Q4 2025 Earnings Call September 29, 2025 5:00 PM EDT Company Participants Joseph Forkey - CEO, President, Treasurer & Director Wayne Coll - CFO & Secretary Conference Call Participants Robert Blum - Lytham Partners, LLC Presentation Operator Good day, and welcome to the Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call. [Operator Instructions] Please note that this event is being recorded.

    https://images.financialmodelingprep.com/news/precision-optics-reports-fourth-quarter-and-fiscal-year-2025-20250929.jpeg
    Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    globenewswire.com

    2025-09-29 16:30:00

    Conference Call Scheduled for today, September 29, 2025, at 5:00pm ET Company introduces fiscal year 2026 Revenue and Adjusted EBITDA guidance Company appoints new Chief Operating Officer GARDNER, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year 2025 for the period ended June 30, 2025.

    https://images.financialmodelingprep.com/news/precision-optics-schedules-fourth-quarter-and-fiscal-year-2025-conference-20250924.jpeg
    Precision Optics Schedules Fourth Quarter and Fiscal Year 2025 Conference Call for September 29, 2025

    globenewswire.com

    2025-09-24 16:15:00

    GARDNER, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's fourth quarter and fiscal year 2025 financial results on Monday, September 29, 2025, at 5:00 p.m. ET.

    https://images.financialmodelingprep.com/news/precision-optics-to-participate-in-the-lytham-partners-2025-20250818.jpg
    Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025

    globenewswire.com

    2025-08-18 16:15:00

    GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 19, 2025.

    https://images.financialmodelingprep.com/news/lacroix-precision-optics-expands-in-batesville-arkansas-creating-107-20250605.jpg
    LaCroix Precision Optics Expands in Batesville, Arkansas, Creating 107 New Jobs

    globenewswire.com

    2025-06-05 14:17:00

    BATESVILLE, Ark., June 05, 2025 (GLOBE NEWSWIRE) -- LaCroix Precision Optics announced that it will be expanding its manufacturing operations in Batesville, Arkansas, creating 107 new jobs over five years.